Alkion BioInnovations

Alkion BioInnovations is a biotechnology company that has developed a proprietary plant tissue propagation and bioproduction platform. The company utilizes innovative hydroponic methods and specialized bioreactors to stimulate plant genes, enabling the production of high-value active compounds with high yields, purity, and batch-to-batch consistency. By employing a carbon-neutral approach in confined bioreactors, their technology provides an alternative to traditional, often unsustainable, extraction methods. The platform is designed to produce a variety of molecules, including vaccine adjuvants like QS-21, recombinant proteins, and natural sweeteners, while significantly reducing production costs, energy usage, and environmental impact compared to conventional greenhouse cultivation.

These solutions are critical for partners and customers in the pharmaceutical, nutraceutical, and agrifood industries who require scalable, sustainable, and secure supply chains for rare or difficult-to-source natural ingredients. By enabling large-scale, year-round production of potent molecules in a controlled environment, Alkion helps address supply chain constraints for essential medical treatments and food ingredients. The company has gained industry recognition, including support from the European Innovation Council Accelerator and various research grants, and works with global health organizations and industrial partners to improve the accessibility and affordability of breakthrough active compounds.